> Skip repeated content
photo of Kimberly (Showalter) Lakin, MD, MS

Kimberly (Showalter) Lakin, MD, MS

Rheumatology
phone icon

About Dr. Lakin

Dr. Kimberly Lakin specializes in the care of patients with various rheumatic conditions including systemic sclerosis (scleroderma), Raynaud’s phenomenon, mixed connective tissue disease, systemic lupus erythematosus, and others, and has a particular interest in systemic sclerosis. Dr. Lakin is also actively involved as an investigator in numerous clinical and translational studies focusing on systemic sclerosis.

Dr. Lakin received her Bachelor of Science from the University of Virginia. She attended medical school at Georgetown University where she graduated cum laude. She completed residency training in internal medicine at Northwestern University and her rheumatology fellowship training at HSS. Additionally, she received her master's degree in clinical and translational research from Weill Cornell Medicine.

Currently, she conducts clinical and translational research in systemic sclerosis, with a focus on testing novel therapeutics, improving trial outcome measurement tools, and determining predictive patient factors that may assist with personalized disease management. She has received funding and recognition for her research including the Rheumatology Research Foundation Resident Research Preceptorship Award, the Scleroderma Clinical Trials Consortium Young Investigator Award, and the Scleroderma Foundation New Investigator Grant.

Profile Video

Departments

Specialized Centers

Scleroderma, Vasculitis & Myositis Center of Excellence

Special Expertise

Scleroderma (systemic sclerosis and localized scleroderma)
Raynaud Phenomenon
Mixed connective tissue disease
Myositis
Inflammatory arthritis
Systemic lupus erythematosus
Sjogren's Syndrome
Vasculitis

Procedures

Intra-articular aspirations and injections
Skin biopsy

Patient Stories

Videos

Insurance

If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.

Credentials

Appointments

Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College

Affiliations

Member, American College of Rheumatology
Member, American Medical Association

Certification

American Board of Internal Medicine, Internal Medicine, 2017
American Board of Internal Medicine, Rheumatology, 2019

Awards

Charles L. Christian Award for Excellence in Musculoskeletal Research, 2020
Scleroderma Clinical Trials Consortium, Travel Award, 2020
Scleroderma Clinical Trials Consortium, Young Investigator Award, 2019
Alpha Omega Alpha Honor Society, 2013
Scleroderma Foundation New Investigator Grant, 2020

Education

Georgetown University School of Medicine, 2014

Internship

Internal Medicine, McGaw Medical Center of Northwestern University, 2015

Residency

Internal Medicine, McGaw Medical Center of Northwestern University, 2017

Fellowship

Rheumatology, Hospital for Special Surgery, 2020

State Licensure

Languages

English

For My Patients

Publications by Dr. Lakin

Professional Education

Selected Journal Articles

Showalter K, Hoffmann A, Richardson C, Aaby D, Lee J, Dematte J, Agrawal R, Savas H, Wu X, Chang RW, Hinchcliff M. Esophageal Dilation and Other Clinical Factors Associated with Pulmonary Function Decline in Patients with Systemic Sclerosis. Journal of Rheumatology Jul 2021, jrheum.210533; DOI: 10.3899/jrheum.210533

Showalter K, Pinheiro, L, Jannat-Khah, D, Sobol I. Szymonifka, J, Finik, J, Steen, V, Gordon, JK. Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry. Rheumatology, 2021;, https://doi.org/10.1093/rheumatology/keab569

Showalter K, Ma X, Pinheiro L, Sobol I, Gordon JK. Thirty-day hospital readmission in systemic sclerosis associated pulmonary hypertension: A nationwide study. Seminars in Arthritis and Rheumatism. 2021;51(1):324-330 doi.org/10.1016/j.semarthrit.2021.01.002.

Showalter K and Gordon JK. Skin Histology in Systemic Sclerosis: A Relevant Clinical Biomarker. Curr Rheumatol Rep. 2020 Nov 26;23(1):3. doi: 10.1007/s11926-020-00970-z

Showalter K, Magro C, Zhang Y, Spiera R, Orange DE, Gordon JK. Response to: 'Correspondence on 'Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement'' by Manetti. Ann Rheum Dis. 2020 Nov 6:annrheumdis-2020-219292. doi: 10.1136/annrheumdis-2020-219292. Epub ahead of print. PMID: 33158883

Showalter K, Spiera R, Magro C, Agius, P, Martyanov V, Franks J, Sharma R, Geiger H, Wood T, Zhang Y, Hayle C, Finik J, Whitfield ML, Orange DE, Gordon JK. Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarization as a hallmark of clinical severity and improvement. (2020) Annals of the Rheumatic Diseases. Published Online First: 07 October 2020. doi: 10.1136/annrheumdis-2020-217840

Showalter K, Merkel P, Khanna, D, Gordon JK. Assessment of Skin Disease in Scleroderma: Practices and Opinions of Investigators Studying Scleroderma. (2020) Journal of Scleroderma and Related Diseases. doi.org/10.1177/2397198320921044

Showalter K, Wu X, Gordon JK. Progressive Dyspnea and Cough in a Healthy, Young Man. Grand Rounds from HSS: Management of Complex Cases. 2019;8(3):3.

Showalter K, Hoffmann A, DeCredico N, Thakrar A, Arroyo E, Goldberg I, Hinchcliff M. Complementary Therapies for Patients with Systemic Sclerosis. (2019) Journal of Scleroderma and Related Diseases. 4(3), 187-199

Showalter K, Hoffmann A, Rouleau G, Aaby D, Lee J, Richardson C, Dematte, J, Agrawal R, Chang RW, Hinchcliff M. (2018) Performance of forced vital capacity and lung diffusion cut-points for associated radiographic interstitial lung disease in systemic sclerosis. Journal of Rheumatology. 46(3), 1572-1576.

Showalter K and Bass A. Polyglandular inflammation following immunotherapy for metastatic renal cell carcinoma. Grand Rounds from HSS: Management of Complex Cases. 2018;7(3):3.

Selected Presentations

Showalter K., Hoffmann A., Rouleau G., Aaby D., Lee J., Richardson C., Dematte J., Agrawal R., Chang R.W., Hinchcliff M. Performance of forced vital capacity and lung diffusion cut-points for associated radiographic interstitial lung disease in systemic sclerosis. Abstract for poster presentation. American College of Rheumatology 2017 Annual Meeting, San Diego, CA, November 2017.

Showalter K., Pinheiro L., Szymonifka J., Sobol I., Steen V., Gordon J.K. Patient-level factors associated with hospital readmission among patients with systemic sclerosis associated pulmonary hypertension. Abstract for poster presentation. American College of Rheumatology 2018 Annual Meeting. Chicago, IL, October 2018.

Showalter K., Magro C., Orange D., Zhang Y., Agius P., Finik J., Spiera R., Gordon J.K. Histologic features correlate with the modified Rodnan skin score, serum inflammatory markers, and patient reported outcomes in patients with early, diffuse cutaneous systemic sclerosis. Abstract for oral presentation. 16th International Workshop on Scleroderma Research, University of Cambridge. Cambridge, U.K., July 2019.

Showalter K., Spiera R., Orange D., Magro C., Zhang Y., Finik J., Gordon J.K. Change in skin histology correlates with the Combined Response Index in Systemic Sclerosis (CRISS) in patients with early, diffuse cutaneous systemic sclerosis. Abstract for oral presentation. American College of Rheumatology 2019 Annual Meeting, Atlanta, GA, November 2019.

Showalter K., Smith M., Cheah J., Ghosh N., Gkrouzman E., Lieber S., Sattui Cortes S., Schwartz N., Schwartzman M., Berman J., Sammaritano L., Bass A. Reproductive counseling documentation practices for women receiving teratogenic medications in an academic rheumatology clinic serving a Medicaid/Medicare patient population. Abstract for poster presentation. American College of Rheumatology 2019 Annual Meeting, Atlanta, GA, November 2019.

Showalter K., Hoffmann A., Richardson C., Koloms K., Rouleau G., Aaby D., Lee J., Dematte J., Agrawal R., Wu X., Chang R.W., Hinchcliff M. Esophageal dilation and other clinical factors associated with pulmonary function decline in patients with systemic sclerosis. Abstract for poster presentation. American College of Rheumatology 2019 Annual Meeting, Atlanta, GA, November 2019.

Showalter K., Orange D., Magro, C., Agius, P., Martyanov, V., Franks, J., Sharma, R., Geiger, H., Wood, T., Zhang, Y., Spiera, R., Whitfield, M, Gordon, J. CD34 and alpha-smooth muscle actin distinguish scleroderma gene expression subsets using a machine learning approach. Abstract for poster presentation. Systemic Sclerosis World Congress Meeting, Prague, Czech Republic, (Meeting postponed from March 2020 and held virtually July 2020).

Showalter K, Gordon JK, Wu, Y, Kwakkenbos L, Carrier ME, Henry R, Wu Y, Ostbo N, Nordlund J, Bourgeault A, Ayala MC, Discepola MN, Denton C, Mouthon L, Thombs B, Spiera RF. Vaccination Against COVID-19: Self-Reported Experiences of Patients with Systemic Sclerosis in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. Arthritis Rheumatol, 2021: 73 (suppl 10)  ACR Convergence 2021

Research

Dr. Lakin conducts clinical and translational research in systemic sclerosis, with a focus on testing novel therapeutics, improving trial outcome measurement tools, and determining predictive patient factors that may assist with personalized disease management.

Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

As of May 11, 2024, Dr. Lakin reported no relationships with the healthcare industry.

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.

Dr. Lakin in the News